Refresh

AJANTA PHARMA LTD. - USFDA inspection for Paithan plant


Download
09 Feb 2017
Ajanta Pharma Ltd has informed BSE that the Company's Paithan facility was recently inspected by US FDA and the Company has issued one procedural related 483. The Company is in process of responding to the same within the stipulated time prescribed by US FDA.

Source: BSE India

View all announcements for AJANTA PHARMA LTD.
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com